drugset / Trial / NCT05665270

A Study for Post op Inflammation After Cataract Surgery

NCT05665270 ↗

Phase 4 Unknown 40 enrolled Wyse Eyecare
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomized, controlled study to assess the safety and effectiveness of treatment with an intracanalicular dexamethasone (0.4mg) insert when utilized in conjunction with topical steroids as part of an extended taper steroid regimen following cataract surgery in patients with a history of epiretinal membrane, diabetic retinopathy, or non-exudative macular degeneration.

Timeline

Start
2023-01-30
Primary completion
2023-10-31
Completion
2023-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg Other
Comparator Prednisolone Other / unclassified 1 % Topical

Indications